Ignite Creation Date:
2024-05-05 @ 4:39 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00284713
Status:
COMPLETED
Last Update Posted:
2009-02-18
First Post:
2006-01-31
Brief Title:
Progenitor Cell Therapy in Dilative Cardiomyopathy
Sponsor:
Johann Wolfgang Goethe University Hospital
Organization:
Johann Wolfgang Goethe University Hospital
Study Overview
Official Title:
Transplantation Of Progenitor Cells And Recovery Of Left Ventricular Function In Patients With Nonischemic Dilatative Cardiomyopathy
Status:
COMPLETED
Status Verified Date:
2009-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Intracoronary infusion of bone marrow derived progenitor cells into the LAD in patients with non ischemic dilated cardiomyopathy
Detailed Description:
Initial clinical pilot trials suggested that intracoronary infusion of bone marrow-derived progenitor cells BMC may enhance left ventricular functional recovery in patients with acute myocardial infarction It is unknown however whether such a strategy might also be applicable to patients with non-ischemic dilated cardiomyopathy DCM Therefore we initiated the TOPCARE-DCM - trial Transplantation Of Progenitor Cells And Recovery of Left Ventricular Function in Patients with non ischemic Dilatative CardioMyopathy aiming to regionally improve left ventricular contractility by selective infusion of BMC into the left anterior descending coronary artery
Patients will be randomized 21 2010 BMC Infusion versus standard medical therapy
Patients will be randomized 21 2010 BMC Infusion versus standard medical therapy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None